As of May 18
| -0.04 / -1.05%|
The 1 analysts offering 12-month price forecasts for Nymox Pharmaceutical Corp have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +138.10% increase from the last price of 3.78.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.